Abivax S.A.
ABVX.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -€176,242 | -€147,740 | -€69,846 | -€41,357 |
| Dep. & Amort. | €1,100 | €707 | €71 | €156 |
| Deferred Tax | €0 | €0 | €1,022 | -€1,141 |
| Stock-Based Comp. | €20,224 | €8,179 | -€1,164 | €828 |
| Change in WC | €1,423 | €21,265 | -€10,089 | -€1,414 |
| Other Non-Cash | -€577 | €20,459 | €14,427 | -€2,730 |
| Operating Cash Flow | -€154,072 | -€97,130 | -€65,579 | -€45,657 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -€643 | -€265 | -€3,968 | -€1,642 |
| Net Acquisitions | €0 | €0 | €14 | €312 |
| Inv. Purchases | €0 | -€9,351 | -€142 | -€9 |
| Inv. Sales/Matur. | €0 | €741 | €390 | €9 |
| Other Inv. Act. | €16,405 | €780 | -€21 | -€126 |
| Investing Cash Flow | €15,762 | -€8,095 | -€3,727 | -€1,456 |
| Financing Activities | – | – | – | – |
| Debt Repay. | €37,486 | €15,239 | -€9,711 | €19,127 |
| Stock Issued | €434 | €353,387 | €46,374 | €69,683 |
| Stock Repurch. | €0 | €0 | €0 | €0 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | -€9,713 | -€33,336 | -€4,452 | -€6,131 |
| Financing Cash Flow | €28,207 | €335,290 | €32,211 | €82,679 |
| Forex Effect | €2,382 | -€5,072 | -€1 | €0 |
| Net Chg. in Cash | -€107,721 | €224,992 | -€33,751 | €31,399 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €251,942 | €26,950 | €60,695 | €29,296 |
| End Cash | €144,221 | €251,942 | €26,944 | €60,695 |
| Free Cash Flow | -€154,715 | -€97,395 | -€69,547 | -€47,299 |